{"id":62223,"date":"2025-11-18T13:06:45","date_gmt":"2025-11-18T12:06:45","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/"},"modified":"2025-11-18T13:06:45","modified_gmt":"2025-11-18T12:06:45","slug":"landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/","title":{"rendered":"Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical\u2019s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nPeer-reviewed data published in <i>Neurosurgery <\/i>show that SOLOPASS<sup>\u00ae<\/sup> 2.0 delivers significantly higher accuracy than free-hand EVD placement.<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\nSOLOPASS<sup>\u00ae<\/sup> 2.0 achieved consistent accuracy across all clinician experience levels.<\/li>\n<\/ul>\n<p>BLUE BELL, Pa.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.intraventmedical.com%2F&amp;esheet=54359672&amp;newsitemid=20251118971409&amp;lan=en-US&amp;anchor=inTRAvent+Medical+Partners+LP&amp;index=1&amp;md5=e4b8351a6351724ec2717c4c212b006c\" rel=\"nofollow\" shape=\"rect\">inTRAvent Medical Partners LP<\/a>, a pioneer in bedside, image-guided neurosurgical innovation, today announced the publication of a peer-reviewed study in <i>Neurosurgery <\/i>evaluating the accuracy of external ventricular drain (EVD) placement using its ultrasound-guided neuronavigation platform, SOLOPASS<sup>\u00ae<\/sup> 2.0.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251118971409\/en\/2646976\/5\/inTRAvent_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251118971409\/en\/2646976\/22\/inTRAvent_logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251118971409\/en\/2646976\/5\/inTRAvent_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251118971409\/en\/2646976\/21\/inTRAvent_logo.jpg\"><\/a><\/p>\n<p>\nThe study, \u201c<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fjournals.lww.com%2Fneurosurgery%2Fabstract%2F9900%2Fevaluation_of_a_novel%2C_bedside%2C_ultrasonographic.1955.aspx&amp;esheet=54359672&amp;newsitemid=20251118971409&amp;lan=en-US&amp;anchor=Evaluation+of+a+Novel%2C+Bedside%2C+Ultrasonographic+Neuronavigation+System+Versus+Free-Hand+Ventricular+Targeting%3A+A+Double-Blinded%2C+Prospective%2C+Paired+Comparison+Study&amp;index=2&amp;md5=7de781e51319f896e9fad73a15267b67\" rel=\"nofollow\" shape=\"rect\">Evaluation of a Novel, Bedside, Ultrasonographic Neuronavigation System Versus Free-Hand Ventricular Targeting: A Double-Blinded, Prospective, Paired Comparison Study<\/a>,\u201d<sup>1<\/sup> showed that the SOLOPASS<sup>\u00ae<\/sup> 2.0 System delivered substantial improvements in placement accuracy and potential safety compared with traditional freehand techniques. It was published Nov. 13, 2025 in <i>Neurosurgery<\/i>.<\/p>\n<p>\nIn a prospective, double-blinded, repeated-measures experiment, 25 participants ranging from first-year medical students to attending neurosurgeons performed simulated EVD placements using both conventional freehand techniques and SOLOPASS<sup>\u00ae<\/sup> 2.0 ultrasound-guided neuronavigation techniques on anatomically realistic, life-sized cranial models.<\/p>\n<p>\n<b>Key Findings:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n98% of placements using SOLOPASS<sup>\u00ae<\/sup> 2.0 entered the ventricular system, versus only 10% of freehand placements.<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n86% of placements using SOLOPASS<sup>\u00ae<\/sup> 2.0 accurately reached the ipsilateral frontal horn target, compared to only 8% with freehand techniques (P &lt; 0.001).<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\nThe mean miss margin was less than 0.5mm using SOLOPASS<sup>\u00ae<\/sup> 2.0, compared to nearly 8mm using freehand guidance (P &lt; 0.001).<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\nSOLOPASS<sup>\u00ae<\/sup> 2.0 consistently delivered superior first-pass accuracy across all levels of neurosurgical experience<b>, <\/b>demonstrating consistent performance regardless of operator skill.<\/li>\n<\/ul>\n<p>\n\u201cThese findings highlight the transformative potential of ultrasound-guided neuronavigation for safer, more precise ventricular access,\u201d said <b>Dr. Kevin Foley, inTRAvent\u2019s Chief Innovation Officer<\/b>. \u201cSOLOPASS 2.0<sup>\u00ae<\/sup> empowers clinicians at every experience level to achieve accurate ventricular placement by delivering real-time imaging on an intuitive, easy-to-use platform\u2014an essential advancement for neurosurgical and critical care patients alike.\u201d<\/p>\n<p>\n\u201cIn modern medicine, quality and safety are paramount,\u201d said <b>Dr. Adam Arthur, Chief Clinical Strategy Officer<\/b>. \u201cThe study reinforces our commitment to advancing real-time image guidance and precision in neurosurgery. By integrating portable ultrasound into bedside ventricular procedures, inTRAvent aims to reduce complications, improve outcomes, and expand the accessibility of high-precision care across the spectrum of clinical settings.\u201d<\/p>\n<p>\n<b>About inTRAvent Medical Partners<\/b><\/p>\n<p>\ninTRAvent Medical Partners is a medical device company dedicated to bringing intra-operative imaging and navigation to the bedside to improve the safety and efficacy of neurosurgical procedures. The Company\u2019s FDA Cleared SOLOPASS<sup>\u00ae<\/sup> platform enables simple, portable neuro-navigation using 2D and 3D ultrasound imaging, artificial intelligence, and trajectory guidance for intra-procedural localization and navigation. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.inTRAventMedical.com&amp;esheet=54359672&amp;newsitemid=20251118971409&amp;lan=en-US&amp;anchor=www.inTRAventMedical.com&amp;index=3&amp;md5=e002ee21fc7c8c861c10b05fa853545b\" rel=\"nofollow\" shape=\"rect\">www.inTRAventMedical.com<\/a>, or find us on LinkedIn.<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"2\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n__________________________<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"2\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<sup>1<\/sup> Himel SM, et al. <i>Evaluation of a Novel, Bedside, Ultrasonographic Neuronavigation System Versus Free-Hand Ventricular Targeting: A Double-Blinded, Prospective, Paired Comparison Study.<\/i> Neurosurgery. November 13, 2025. DOI: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdoi.org%2F10.1227%2Fneu.0000000000003855&amp;esheet=54359672&amp;newsitemid=20251118971409&amp;lan=en-US&amp;anchor=10.1227%2Fneu.0000000000003855&amp;index=4&amp;md5=f837f30c1f25ee6b0da9dfc841a0cc21\" rel=\"nofollow\" shape=\"rect\">10.1227\/neu.0000000000003855<\/a><\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\n\u00a0<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Contact<\/b><br \/>Brad Perriello<br \/>\n<br \/>Circle Hill Communications<br \/>\n<br \/>617.817.1385<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#58;&#x62;r&#97;&#x64;&#64;&#99;&#x69;r&#99;&#x6c;e&#104;&#x69;l&#108;&#x63;o&#109;&#x6d;u&#110;&#x69;c&#97;&#x74;i&#x6f;&#x6e;s&#x2e;&#x63;&#111;&#x6d;\" rel=\"nofollow\" shape=\"rect\">brad&#64;c&#105;&#114;&#99;&#108;&#101;&#104;&#105;&#x6c;&#x6c;&#x63;&#x6f;&#x6d;&#x6d;&#x75;&#x6e;&#x69;&#x63;&#x61;&#x74;ions&#46;c&#111;&#109;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Peer-reviewed data published in Neurosurgery show that SOLOPASS\u00ae 2.0 delivers significantly higher accuracy than free-hand EVD placement. SOLOPASS\u00ae 2.0 achieved consistent accuracy across all clinician experience levels. BLUE BELL, Pa.&#8211;(BUSINESS WIRE)&#8211;inTRAvent Medical Partners LP, a pioneer in bedside, image-guided neurosurgical innovation, today announced the publication of a peer-reviewed study in Neurosurgery evaluating the accuracy of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62223","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical\u2019s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical\u2019s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Peer-reviewed data published in Neurosurgery show that SOLOPASS\u00ae 2.0 delivers significantly higher accuracy than free-hand EVD placement. SOLOPASS\u00ae 2.0 achieved consistent accuracy across all clinician experience levels. BLUE BELL, Pa.&#8211;(BUSINESS WIRE)&#8211;inTRAvent Medical Partners LP, a pioneer in bedside, image-guided neurosurgical innovation, today announced the publication of a peer-reviewed study in Neurosurgery evaluating the accuracy of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-18T12:06:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251118971409\/en\/2646976\/22\/inTRAvent_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical\u2019s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System\",\"datePublished\":\"2025-11-18T12:06:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/\"},\"wordCount\":463,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251118971409\\\/en\\\/2646976\\\/22\\\/inTRAvent_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/\",\"name\":\"Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical\u2019s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251118971409\\\/en\\\/2646976\\\/22\\\/inTRAvent_logo.jpg\",\"datePublished\":\"2025-11-18T12:06:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251118971409\\\/en\\\/2646976\\\/22\\\/inTRAvent_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251118971409\\\/en\\\/2646976\\\/22\\\/inTRAvent_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical\u2019s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical\u2019s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/","og_locale":"en_US","og_type":"article","og_title":"Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical\u2019s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System - Pharma Trend","og_description":"Peer-reviewed data published in Neurosurgery show that SOLOPASS\u00ae 2.0 delivers significantly higher accuracy than free-hand EVD placement. SOLOPASS\u00ae 2.0 achieved consistent accuracy across all clinician experience levels. BLUE BELL, Pa.&#8211;(BUSINESS WIRE)&#8211;inTRAvent Medical Partners LP, a pioneer in bedside, image-guided neurosurgical innovation, today announced the publication of a peer-reviewed study in Neurosurgery evaluating the accuracy of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-18T12:06:45+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251118971409\/en\/2646976\/22\/inTRAvent_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical\u2019s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System","datePublished":"2025-11-18T12:06:45+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/"},"wordCount":463,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251118971409\/en\/2646976\/22\/inTRAvent_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/","url":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/","name":"Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical\u2019s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251118971409\/en\/2646976\/22\/inTRAvent_logo.jpg","datePublished":"2025-11-18T12:06:45+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251118971409\/en\/2646976\/22\/inTRAvent_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251118971409\/en\/2646976\/22\/inTRAvent_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/landmark-bench-study-shows-dramatic-improvement-in-ventricular-catheter-placement-accuracy-with-intravent-medicals-first-in-class-fda-cleared-solopass-2-0-ultrasound-guided-neuronavigation-s\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical\u2019s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62223"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62223\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62223"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}